Some hospitals had invested significant funds in the older machines, and had not yet reached the point where they were paid off. Should competition have a free hand in this situation if the patients do not understand the quality differences? If a hospital makes an investment in new technology only to see a competitor promote a new technology more effectively, does that discourage institutions from investing in machines that can be useful in healthcare?